JP2022516631A5 - - Google Patents
Info
- Publication number
- JP2022516631A5 JP2022516631A5 JP2021538743A JP2021538743A JP2022516631A5 JP 2022516631 A5 JP2022516631 A5 JP 2022516631A5 JP 2021538743 A JP2021538743 A JP 2021538743A JP 2021538743 A JP2021538743 A JP 2021538743A JP 2022516631 A5 JP2022516631 A5 JP 2022516631A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- independently
- disease
- substituted
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962788049P | 2019-01-03 | 2019-01-03 | |
| US62/788,049 | 2019-01-03 | ||
| US201962879374P | 2019-07-26 | 2019-07-26 | |
| US62/879,374 | 2019-07-26 | ||
| PCT/US2020/012268 WO2020142748A1 (en) | 2019-01-03 | 2020-01-03 | Methods and materials for increasing transcription factor eb polypeptide levels |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022516631A JP2022516631A (ja) | 2022-03-01 |
| JP2022516631A5 true JP2022516631A5 (enExample) | 2023-01-06 |
| JP7566753B2 JP7566753B2 (ja) | 2024-10-15 |
Family
ID=71406977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021538743A Active JP7566753B2 (ja) | 2019-01-03 | 2020-01-03 | 転写因子ｅｂポリペプチドレベルを増加させるための方法および材料 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12286442B2 (enExample) |
| EP (1) | EP3906033A4 (enExample) |
| JP (1) | JP7566753B2 (enExample) |
| KR (1) | KR102904932B1 (enExample) |
| CN (1) | CN113316453B (enExample) |
| AU (1) | AU2020204717B2 (enExample) |
| BR (1) | BR112021012950A2 (enExample) |
| CA (1) | CA3123902A1 (enExample) |
| IL (1) | IL284403A (enExample) |
| MX (1) | MX2021008152A (enExample) |
| SG (1) | SG11202105685TA (enExample) |
| WO (1) | WO2020142748A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022013684A1 (en) | 2020-07-11 | 2022-01-20 | Pfizer Inc. | Antiviral heteroaryl ketone derivatives |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| CZ309449B6 (cs) * | 2020-12-24 | 2023-01-25 | Ústav experimentální botaniky AV ČR, v. v. i. | Chinazolinové deriváty jako selektivní inhibitory cyklooxygenázy-1 |
| CN113248518B (zh) * | 2021-06-21 | 2022-03-25 | 山东大学 | 嘧啶哌嗪类衍生物及其制备方法与应用 |
| WO2025026988A1 (en) * | 2023-07-28 | 2025-02-06 | Theranexus | Mutated tfeb for treating lysosomal disorders |
| CN119818678A (zh) * | 2024-12-24 | 2025-04-15 | 广州医科大学附属妇女儿童医疗中心 | Tfeb在制备变应性鼻炎的药物中的应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5304121A (en) | 1990-12-28 | 1994-04-19 | Boston Scientific Corporation | Drug delivery system making use of a hydrogel polymer coating |
| US5716981A (en) | 1993-07-19 | 1998-02-10 | Angiogenesis Technologies, Inc. | Anti-angiogenic compositions and methods of use |
| US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
| ES2266258T3 (es) | 2000-09-15 | 2007-03-01 | Vertex Pharmaceuticals Incorporated | Compuestos de pirazol utiles como inhibidores de proteina cinasas. |
| JP2005503425A (ja) | 2001-05-24 | 2005-02-03 | アレックザ モレキュラー デリヴァリー コーポレイション | 所定の吸入ルートによる薬剤エステルの送出 |
| US20030158195A1 (en) * | 2001-12-21 | 2003-08-21 | Cywin Charles L. | 1,6 naphthyridines useful as inhibitors of SYK kinase |
| WO2004037814A1 (en) * | 2002-10-25 | 2004-05-06 | Vertex Pharmaceuticals Incorporated | Indazolinone compositions useful as kinase inhibitors |
| CL2004000409A1 (es) | 2003-03-03 | 2005-01-07 | Vertex Pharma | Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu |
| US7198926B2 (en) | 2003-05-08 | 2007-04-03 | E. I. Du Pont De Nemours And Company | Preparation of (E)- and (Z)-2-methyl-2-butenoic acids |
| WO2004101512A2 (en) * | 2003-05-13 | 2004-11-25 | Smithkline Beecham Corporation | Naphthyridine integrase inhibitors |
| US20090209536A1 (en) * | 2007-06-17 | 2009-08-20 | Kalypsys, Inc. | Aminoquinazoline cannabinoid receptor modulators for treatment of disease |
| CN101917999A (zh) * | 2007-11-07 | 2010-12-15 | 弗尔德里克斯制药股份有限公司 | 蛋白质运输的调节 |
| WO2010015520A1 (de) | 2008-08-05 | 2010-02-11 | Boehringer Ingelheim International Gmbh | Substituierte naphthyridine und ihre verwendung als arzneimittel |
| EP2313406B1 (de) * | 2008-08-05 | 2015-02-25 | Boehringer Ingelheim International GmbH | 4-dimethylaminophenyl-substituierte napththyridine und ihre verwendung als arzneimittel |
| GB201007203D0 (en) * | 2010-04-29 | 2010-06-16 | Glaxo Group Ltd | Novel compounds |
| GB201007347D0 (en) * | 2010-04-30 | 2010-06-16 | Karus Therapeutics Ltd | Compounds |
| EP2922540A1 (en) | 2012-11-20 | 2015-09-30 | F. Hoffmann-La Roche AG | Substituted 1,6-naphthyridines |
| US20170354666A1 (en) * | 2014-11-19 | 2017-12-14 | Rush University Medical Center | Compositions and methods for treating lysosomal disorders |
| WO2018089499A1 (en) | 2016-11-08 | 2018-05-17 | Navitor Pharmaceuticals, Inc. | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF |
| WO2018089493A1 (en) | 2016-11-08 | 2018-05-17 | Navitor Pharmaceuticals, Inc. | PYRROLE mTORC INHIBITORS AND USES THEREOF |
| WO2018089433A1 (en) * | 2016-11-08 | 2018-05-17 | Navitor Pharmaceuticals, Inc. | PHENYL mTORC INHIBITORS AND USES THEREOF |
| WO2018191146A1 (en) | 2017-04-10 | 2018-10-18 | Navitor Pharmaceuticals, Inc. | Heteroaryl rheb inhibitors and uses thereof |
-
2020
- 2020-01-03 JP JP2021538743A patent/JP7566753B2/ja active Active
- 2020-01-03 SG SG11202105685TA patent/SG11202105685TA/en unknown
- 2020-01-03 MX MX2021008152A patent/MX2021008152A/es unknown
- 2020-01-03 BR BR112021012950-2A patent/BR112021012950A2/pt unknown
- 2020-01-03 KR KR1020217022772A patent/KR102904932B1/ko active Active
- 2020-01-03 US US17/420,597 patent/US12286442B2/en active Active
- 2020-01-03 AU AU2020204717A patent/AU2020204717B2/en active Active
- 2020-01-03 WO PCT/US2020/012268 patent/WO2020142748A1/en not_active Ceased
- 2020-01-03 CN CN202080007921.4A patent/CN113316453B/zh active Active
- 2020-01-03 CA CA3123902A patent/CA3123902A1/en active Pending
- 2020-01-03 EP EP20736104.9A patent/EP3906033A4/en active Pending
-
2021
- 2021-06-27 IL IL284403A patent/IL284403A/en unknown
-
2025
- 2025-01-23 US US19/035,805 patent/US20250382309A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7652865B2 (ja) | Ｒｏｃｋ阻害剤としての重水素化合物 | |
| US20240352031A1 (en) | Thieno[2,3-D]pyrimidin-4-one Derivatives as NMDAR Modulators and Uses Related Thereto | |
| JP5778353B2 (ja) | アゼチジン化合物、組成物及び可溶性エポキシド加水分解酵素の阻害剤としてのそれらの使用 | |
| CN85107020A (zh) | 烷基亚磺酰胺基苯基烷基胺的制备方法 | |
| JP2013541596A5 (enExample) | ||
| US7595403B2 (en) | Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors | |
| CN1646538A (zh) | 托吡酯盐及其组合物、制备方法和应用 | |
| JP2018537413A (ja) | Ｃｆｔｒを調節するための化合物、組成物、および方法 | |
| PE20240655A1 (es) | Derivados de acido 4-(2-fluoro-4-metoxi-5-3-(((1-metilciclobutil)metil)carbamoil)biciclo[2.2.1]heptan-2-il)carbamoil)fenoxi)-1-metilciclohexano-1-carboxilico y compuestos similares como moduladores de rxfp1 para el tratamiento de insuficiencia cardiaca | |
| JP2005516067A5 (enExample) | ||
| JP2010138206A (ja) | 新規な複素環式化合物 | |
| CA2472149A1 (en) | New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments | |
| US20250382309A1 (en) | Methods and materials for increasing transcription factor eb polypeptide levels | |
| JP6363164B2 (ja) | ヒストンデアセチラーゼ阻害剤及びその組成物と使用方法 | |
| CA2471578A1 (en) | Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments | |
| WO2010051819A1 (en) | Novel 2,3-diamino-quinazolinone derivatives and their medical use | |
| JP2014506602A5 (enExample) | ||
| US20110312962A1 (en) | Novel 2-morpholino-3-amido-pyridine derivatives and their medical use | |
| JP2023536511A5 (enExample) | ||
| JP2009532413A5 (enExample) | ||
| US9388166B2 (en) | 6-aminoindole derivatives as TRP channel antagonists | |
| MXPA06003770A (es) | Medios desechables en un panal absorbente. | |
| US20110003867A1 (en) | Novel 2-ethyl-methyl-amino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators | |
| RU2021122937A (ru) | Способы и материалы для повышения уровней полипептида фактора транскрипции eb | |
| JP7862858B2 (ja) | Ｍｐｓ１を処置するための併用療法 |